

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 8.75238690 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 7.64993520 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 7.29887814 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.63615172 |
| 5 | blood coagulation, intrinsic pathway (GO:0007597) | 6.13200965 |
| 6 | regulation of platelet aggregation (GO:0090330) | 6.13131666 |
| 7 | regulation of platelet activation (GO:0010543) | 5.92536590 |
| 8 | adenosine receptor signaling pathway (GO:0001973) | 5.82615303 |
| 9 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.64433345 |
| 10 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.46189896 |
| 11 | platelet aggregation (GO:0070527) | 5.42896293 |
| 12 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.40061119 |
| 13 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.37043282 |
| 14 | negative regulation of norepinephrine secretion (GO:0010700) | 5.35389130 |
| 15 | negative regulation of platelet activation (GO:0010544) | 5.30312132 |
| 16 | low-density lipoprotein particle remodeling (GO:0034374) | 5.27153885 |
| 17 | negative regulation of heart rate (GO:0010459) | 5.26183608 |
| 18 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.06240752 |
| 19 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.03982543 |
| 20 | lipoxygenase pathway (GO:0019372) | 5.02513632 |
| 21 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.34885314 |
| 22 | negative regulation of protein localization to cell surface (GO:2000009) | 4.31653174 |
| 23 | platelet degranulation (GO:0002576) | 4.31631220 |
| 24 | neutrophil activation (GO:0042119) | 4.29764578 |
| 25 | beta-amyloid metabolic process (GO:0050435) | 4.24821617 |
| 26 | positive regulation of mast cell activation (GO:0033005) | 4.23454328 |
| 27 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.22668865 |
| 28 | negative regulation of response to food (GO:0032096) | 4.20502027 |
| 29 | negative regulation of appetite (GO:0032099) | 4.20502027 |
| 30 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.17521166 |
| 31 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.13751991 |
| 32 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.12891637 |
| 33 | angiogenesis involved in wound healing (GO:0060055) | 4.11895812 |
| 34 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.03659831 |
| 35 | regulation of integrin activation (GO:0033623) | 3.98111655 |
| 36 | polyamine biosynthetic process (GO:0006596) | 3.97892957 |
| 37 | positive regulation of macrophage differentiation (GO:0045651) | 3.91838788 |
| 38 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.91678917 |
| 39 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.90563302 |
| 40 | high-density lipoprotein particle remodeling (GO:0034375) | 3.87850230 |
| 41 | regulation of lipoprotein metabolic process (GO:0050746) | 3.85063253 |
| 42 | platelet activation (GO:0030168) | 3.84198059 |
| 43 | positive regulation of receptor recycling (GO:0001921) | 3.84041701 |
| 44 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.82472615 |
| 45 | phospholipid homeostasis (GO:0055091) | 3.81912071 |
| 46 | platelet formation (GO:0030220) | 3.79736790 |
| 47 | extracellular fibril organization (GO:0043206) | 3.79577627 |
| 48 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.79443778 |
| 49 | granulocyte activation (GO:0036230) | 3.75476081 |
| 50 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.73767066 |
| 51 | homotypic cell-cell adhesion (GO:0034109) | 3.73504861 |
| 52 | negative regulation of heart contraction (GO:0045822) | 3.69439640 |
| 53 | regulation of norepinephrine secretion (GO:0014061) | 3.68756066 |
| 54 | reverse cholesterol transport (GO:0043691) | 3.68249248 |
| 55 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.64877940 |
| 56 | purinergic receptor signaling pathway (GO:0035587) | 3.64672655 |
| 57 | regulation of cholesterol efflux (GO:0010874) | 3.62408362 |
| 58 | megakaryocyte development (GO:0035855) | 3.59998786 |
| 59 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.52665140 |
| 60 | negative regulation of T cell apoptotic process (GO:0070233) | 3.49300469 |
| 61 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.45797055 |
| 62 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.45706033 |
| 63 | mitochondrial calcium ion transport (GO:0006851) | 3.41939990 |
| 64 | positive regulation of hemostasis (GO:1900048) | 3.39469971 |
| 65 | positive regulation of blood coagulation (GO:0030194) | 3.39469971 |
| 66 | regulation of endothelial cell differentiation (GO:0045601) | 3.39053836 |
| 67 | negative regulation of catecholamine secretion (GO:0033604) | 3.34747223 |
| 68 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.28211848 |
| 69 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25593523 |
| 70 | termination of signal transduction (GO:0023021) | 3.24349550 |
| 71 | vesicle targeting (GO:0006903) | 3.21403412 |
| 72 | autophagic vacuole fusion (GO:0000046) | 3.20066280 |
| 73 | plasma membrane fusion (GO:0045026) | 3.16128125 |
| 74 | regulation of receptor recycling (GO:0001919) | 3.15397124 |
| 75 | fibril organization (GO:0097435) | 3.13535586 |
| 76 | regulation of female receptivity (GO:0045924) | 3.04616467 |
| 77 | sequestering of actin monomers (GO:0042989) | 3.01553493 |
| 78 | positive regulation of coagulation (GO:0050820) | 3.00648894 |
| 79 | L-phenylalanine catabolic process (GO:0006559) | 2.99638884 |
| 80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.99638884 |
| 81 | cyclooxygenase pathway (GO:0019371) | 2.99414212 |
| 82 | regulation of blood coagulation (GO:0030193) | 2.95467781 |
| 83 | regulation of hemostasis (GO:1900046) | 2.95467781 |
| 84 | relaxation of smooth muscle (GO:0044557) | 2.94226673 |
| 85 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.94147529 |
| 86 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.93512270 |
| 87 | leukocyte degranulation (GO:0043299) | 2.93003706 |
| 88 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.91967763 |
| 89 | dopamine transport (GO:0015872) | 2.90134988 |
| 90 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.90084255 |
| 91 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90022781 |
| 92 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.89612562 |
| 93 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.87845563 |
| 94 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.87845563 |
| 95 | endothelium development (GO:0003158) | 2.85292084 |
| 96 | monoamine transport (GO:0015844) | 2.84542585 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.83292698 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.83292698 |
| 99 | tyrosine metabolic process (GO:0006570) | 2.83213962 |
| 100 | phagocytosis, engulfment (GO:0006911) | 2.82997570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 5.19400935 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.56532513 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.89950123 |
| 4 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.29772687 |
| 5 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.22369174 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.08390770 |
| 7 | GATA1_19941826_ChIP-Seq_K562_Human | 3.04666719 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.03719955 |
| 9 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.88485990 |
| 10 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.79417899 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.72181479 |
| 12 | GATA2_19941826_ChIP-Seq_K562_Human | 2.66129785 |
| 13 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.56383202 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.40408958 |
| 15 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.30982334 |
| 16 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.25566214 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.20984975 |
| 18 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.18671672 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17195973 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.16406674 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.15306288 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.14646883 |
| 23 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 2.13506521 |
| 24 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.13386285 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.11516739 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06278053 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05079260 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03758370 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95360850 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85710282 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77833068 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69887196 |
| 33 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.58640980 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58100120 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55817101 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48990992 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46128539 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43459070 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42042238 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41918372 |
| 41 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.40512609 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39627199 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37148751 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37148751 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33038289 |
| 46 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.25346151 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20205352 |
| 48 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.20190265 |
| 49 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19138044 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18791644 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16586013 |
| 52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13354880 |
| 53 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.10665158 |
| 54 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03348008 |
| 55 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01340286 |
| 56 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01018819 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00653382 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99293734 |
| 59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99283033 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97772583 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95247277 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92437460 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.91730881 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90194703 |
| 65 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.88949332 |
| 66 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88801711 |
| 67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86891567 |
| 68 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86512618 |
| 69 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86017308 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85617150 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.85421525 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85272500 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84346125 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.84212016 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81604442 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81465526 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81183161 |
| 78 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81037618 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79871161 |
| 80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.79621049 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79482818 |
| 82 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78977938 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78844839 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78656444 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78402240 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77392331 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77052214 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76382245 |
| 89 | EWS_26573619_Chip-Seq_HEK293_Human | 0.76116376 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.75976521 |
| 91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75533844 |
| 92 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73805056 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.73647425 |
| 94 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.73373674 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.73103101 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.73103101 |
| 97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.73053444 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72717948 |
| 99 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.72430370 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71575346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 5.31343159 |
| 2 | MP0003724_increased_susceptibility_to | 3.64044939 |
| 3 | MP0000465_gastrointestinal_hemorrhage | 3.36149162 |
| 4 | MP0000343_altered_response_to | 2.47946547 |
| 5 | MP0003566_abnormal_cell_adhesion | 2.42037597 |
| 6 | MP0002736_abnormal_nociception_after | 2.37380914 |
| 7 | MP0005083_abnormal_biliary_tract | 2.34969849 |
| 8 | MP0004510_myositis | 2.34789771 |
| 9 | MP0000230_abnormal_systemic_arterial | 2.31062666 |
| 10 | MP0003303_peritoneal_inflammation | 2.24697783 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.10902715 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.07801668 |
| 13 | MP0005410_abnormal_fertilization | 2.01626159 |
| 14 | MP0005464_abnormal_platelet_physiology | 10.5441441 |
| 15 | MP0004084_abnormal_cardiac_muscle | 1.92476730 |
| 16 | MP0003638_abnormal_response/metabolism_ | 1.91083043 |
| 17 | MP0008872_abnormal_physiological_respon | 1.89072962 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 1.85495819 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.83986237 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 1.79705452 |
| 21 | MP0003879_abnormal_hair_cell | 1.79471299 |
| 22 | MP0003828_pulmonary_edema | 1.72243652 |
| 23 | MP0005671_abnormal_response_to | 1.69094183 |
| 24 | MP0008775_abnormal_heart_ventricle | 1.69047031 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.63815638 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.63112656 |
| 27 | MP0004130_abnormal_muscle_cell | 1.55152501 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.52982230 |
| 29 | MP0001851_eye_inflammation | 1.52215997 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.47758137 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.41581688 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.38714343 |
| 33 | MP0001663_abnormal_digestive_system | 1.37809918 |
| 34 | MP0000249_abnormal_blood_vessel | 1.31079033 |
| 35 | MP0002132_abnormal_respiratory_system | 1.30607519 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.28630317 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.28630317 |
| 38 | MP0002398_abnormal_bone_marrow | 1.28462328 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.28312605 |
| 40 | MP0004947_skin_inflammation | 1.26769837 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.25862197 |
| 42 | MP0004215_abnormal_myocardial_fiber | 1.23447579 |
| 43 | MP0009763_increased_sensitivity_to | 1.19374112 |
| 44 | MP0009697_abnormal_copulation | 1.19342605 |
| 45 | MP0003136_yellow_coat_color | 1.14302898 |
| 46 | MP0008874_decreased_physiological_sensi | 1.09907304 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.07016165 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.04871484 |
| 49 | MP0000858_altered_metastatic_potential | 1.03693576 |
| 50 | MP0003866_abnormal_defecation | 1.01648231 |
| 51 | MP0009642_abnormal_blood_homeostasis | 0.99227614 |
| 52 | MP0002723_abnormal_immune_serum | 0.97445557 |
| 53 | MP0001970_abnormal_pain_threshold | 0.96323662 |
| 54 | MP0006276_abnormal_autonomic_nervous | 0.96299016 |
| 55 | MP0009764_decreased_sensitivity_to | 0.95040241 |
| 56 | MP0005501_abnormal_skin_physiology | 0.92934457 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.91658858 |
| 58 | MP0002429_abnormal_blood_cell | 0.91505543 |
| 59 | MP0000015_abnormal_ear_pigmentation | 0.90935652 |
| 60 | MP0001765_abnormal_ion_homeostasis | 0.90862517 |
| 61 | MP0003436_decreased_susceptibility_to | 0.89022450 |
| 62 | MP0000689_abnormal_spleen_morphology | 0.88902775 |
| 63 | MP0005381_digestive/alimentary_phenotyp | 0.88521261 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 0.86352119 |
| 65 | MP0001800_abnormal_humoral_immune | 0.85769539 |
| 66 | MP0005165_increased_susceptibility_to | 0.85594863 |
| 67 | MP0002452_abnormal_antigen_presenting | 0.84888880 |
| 68 | MP0002972_abnormal_cardiac_muscle | 0.83453031 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.82504757 |
| 70 | MP0006138_congestive_heart_failure | 0.80566625 |
| 71 | MP0006054_spinal_hemorrhage | 0.80065851 |
| 72 | MP0005409_darkened_coat_color | 0.79840704 |
| 73 | MP0003011_delayed_dark_adaptation | 0.79068396 |
| 74 | MP0002722_abnormal_immune_system | 0.78996565 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 0.78791873 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 0.78171587 |
| 77 | MP0005385_cardiovascular_system_phenoty | 0.78171587 |
| 78 | MP0005023_abnormal_wound_healing | 0.77941847 |
| 79 | MP0002735_abnormal_chemical_nociception | 0.77423359 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.77299685 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.76949713 |
| 82 | MP0004134_abnormal_chest_morphology | 0.76600283 |
| 83 | MP0001664_abnormal_digestion | 0.75823023 |
| 84 | MP0001756_abnormal_urination | 0.73361258 |
| 85 | MP0002420_abnormal_adaptive_immunity | 0.72940569 |
| 86 | MP0000358_abnormal_cell_content/ | 0.72514268 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.71733730 |
| 88 | MP0001819_abnormal_immune_cell | 0.71694627 |
| 89 | MP0000716_abnormal_immune_system | 0.70665798 |
| 90 | MP0002128_abnormal_blood_circulation | 0.69168765 |
| 91 | MP0000685_abnormal_immune_system | 0.67881413 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.67548890 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.67317575 |
| 94 | MP0009333_abnormal_splenocyte_physiolog | 0.67121367 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.66900131 |
| 96 | MP0005535_abnormal_body_temperature | 0.66273223 |
| 97 | MP0005620_abnormal_muscle_contractility | 0.64918365 |
| 98 | MP0000383_abnormal_hair_follicle | 0.64262882 |
| 99 | MP0003075_altered_response_to | 0.64031159 |
| 100 | MP0003186_abnormal_redox_activity | 0.62188557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 9.53669113 |
| 2 | Purpura (HP:0000979) | 9.12147168 |
| 3 | Epistaxis (HP:0000421) | 7.75069655 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 7.30377547 |
| 5 | Gingival bleeding (HP:0000225) | 6.27560620 |
| 6 | Abnormal platelet function (HP:0011869) | 5.46818486 |
| 7 | Impaired platelet aggregation (HP:0003540) | 5.46818486 |
| 8 | Dyschromatopsia (HP:0007641) | 4.76891041 |
| 9 | Acanthocytosis (HP:0001927) | 4.32840773 |
| 10 | Poikilocytosis (HP:0004447) | 4.17806865 |
| 11 | Spontaneous hematomas (HP:0007420) | 3.93133188 |
| 12 | Conjunctival telangiectasia (HP:0000524) | 3.90915603 |
| 13 | Abnormal pupillary function (HP:0007686) | 3.67330463 |
| 14 | Paralysis (HP:0003470) | 3.43756283 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.41886313 |
| 16 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.37113063 |
| 17 | Bruising susceptibility (HP:0000978) | 3.31619095 |
| 18 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.22895160 |
| 19 | Abnormality of lateral ventricle (HP:0030047) | 3.13524094 |
| 20 | Xanthomatosis (HP:0000991) | 2.85449298 |
| 21 | Abnormal auditory evoked potentials (HP:0006958) | 2.77870605 |
| 22 | Decreased central vision (HP:0007663) | 2.76381809 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.70781028 |
| 24 | Increased density of long bones (HP:0006392) | 2.69901193 |
| 25 | Upper limb muscle weakness (HP:0003484) | 2.68786399 |
| 26 | Hepatosplenomegaly (HP:0001433) | 2.65418865 |
| 27 | Joint swelling (HP:0001386) | 2.58512893 |
| 28 | Male infertility (HP:0003251) | 2.50499155 |
| 29 | Generalized aminoaciduria (HP:0002909) | 2.49632185 |
| 30 | Increased IgM level (HP:0003496) | 2.45880586 |
| 31 | Joint hemorrhage (HP:0005261) | 2.36693197 |
| 32 | Stomatitis (HP:0010280) | 2.31436637 |
| 33 | Nausea (HP:0002018) | 2.30134030 |
| 34 | Papillary thyroid carcinoma (HP:0002895) | 2.25345708 |
| 35 | Tinnitus (HP:0000360) | 2.23474668 |
| 36 | Ventricular fibrillation (HP:0001663) | 2.22752921 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.21564840 |
| 38 | Abnormality of iron homeostasis (HP:0011031) | 2.12925461 |
| 39 | Thyroid-stimulating hormone excess (HP:0002925) | 2.12080245 |
| 40 | Dysautonomia (HP:0002459) | 2.09423476 |
| 41 | Abnormal ciliary motility (HP:0012262) | 2.08955256 |
| 42 | Spontaneous abortion (HP:0005268) | 2.06563502 |
| 43 | Prolonged bleeding time (HP:0003010) | 11.8702643 |
| 44 | Menorrhagia (HP:0000132) | 11.1134229 |
| 45 | Increased mean platelet volume (HP:0011877) | 10.7978035 |
| 46 | Abnormal platelet volume (HP:0011876) | 10.1100187 |
| 47 | Hyperthyroidism (HP:0000836) | 1.98101417 |
| 48 | Hypophosphatemic rickets (HP:0004912) | 1.96446339 |
| 49 | Tongue fasciculations (HP:0001308) | 1.91553403 |
| 50 | 3-Methylglutaconic aciduria (HP:0003535) | 1.88607598 |
| 51 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88382773 |
| 52 | Biliary tract neoplasm (HP:0100574) | 1.86908844 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 1.86222417 |
| 54 | Myocardial infarction (HP:0001658) | 1.76295728 |
| 55 | Episodic fever (HP:0001954) | 1.74207835 |
| 56 | Muscle fibrillation (HP:0010546) | 1.73213611 |
| 57 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.71958313 |
| 58 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.71958313 |
| 59 | Increased serum ferritin (HP:0003281) | 1.71141158 |
| 60 | Encephalitis (HP:0002383) | 1.69094483 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.67467654 |
| 62 | Arterial thrombosis (HP:0004420) | 1.64359126 |
| 63 | Infertility (HP:0000789) | 1.64277093 |
| 64 | Polycythemia (HP:0001901) | 1.63173500 |
| 65 | Arthropathy (HP:0003040) | 1.62897501 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 1.60587980 |
| 67 | Obstructive lung disease (HP:0006536) | 1.60587980 |
| 68 | Renal Fanconi syndrome (HP:0001994) | 1.56580765 |
| 69 | Polyphagia (HP:0002591) | 1.56076444 |
| 70 | Abnormality of the prostate (HP:0008775) | 1.55682418 |
| 71 | Thyroid carcinoma (HP:0002890) | 1.55434233 |
| 72 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.55341345 |
| 73 | Basal ganglia calcification (HP:0002135) | 1.55293003 |
| 74 | Leiomyosarcoma (HP:0100243) | 1.51904426 |
| 75 | Uterine leiomyosarcoma (HP:0002891) | 1.51904426 |
| 76 | Vertigo (HP:0002321) | 1.50530426 |
| 77 | Lower limb amyotrophy (HP:0007210) | 1.47870286 |
| 78 | Testicular neoplasm (HP:0010788) | 1.47598498 |
| 79 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.46792913 |
| 80 | Abnormality of alanine metabolism (HP:0010916) | 1.46459233 |
| 81 | Hyperalaninemia (HP:0003348) | 1.46459233 |
| 82 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.46459233 |
| 83 | Mitral stenosis (HP:0001718) | 1.45399635 |
| 84 | Termporal pattern (HP:0011008) | 1.43837060 |
| 85 | Insidious onset (HP:0003587) | 1.43837060 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 1.41251618 |
| 87 | Back pain (HP:0003418) | 1.40886045 |
| 88 | Absent/shortened dynein arms (HP:0200106) | 1.38148529 |
| 89 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.38148529 |
| 90 | Mucosal telangiectasiae (HP:0100579) | 1.36725715 |
| 91 | Ileus (HP:0002595) | 1.36029054 |
| 92 | Abnormal spermatogenesis (HP:0008669) | 1.34327756 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.33271590 |
| 94 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.32952942 |
| 95 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.30793910 |
| 96 | Bladder neoplasm (HP:0009725) | 1.30377153 |
| 97 | Bladder carcinoma (HP:0002862) | 1.30377153 |
| 98 | Neoplasm of the rectum (HP:0100743) | 1.29549157 |
| 99 | Central scotoma (HP:0000603) | 1.29527344 |
| 100 | Hypertriglyceridemia (HP:0002155) | 1.28531035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 5.68111040 |
| 2 | RIPK4 | 4.91340253 |
| 3 | BMX | 4.41290567 |
| 4 | MYLK | 4.06162870 |
| 5 | EIF2AK1 | 3.24593908 |
| 6 | BTK | 2.92675735 |
| 7 | TEC | 2.89288862 |
| 8 | PTK2B | 2.84970189 |
| 9 | ILK | 2.40645768 |
| 10 | GRK5 | 2.30058646 |
| 11 | TAOK3 | 2.23920717 |
| 12 | CSF1R | 2.17226390 |
| 13 | SYK | 2.03225895 |
| 14 | ZAP70 | 1.97129913 |
| 15 | PIK3CG | 1.95706203 |
| 16 | MAPKAPK3 | 1.90133029 |
| 17 | GRK6 | 1.88495402 |
| 18 | BMPR2 | 1.87835340 |
| 19 | FGR | 1.63022283 |
| 20 | STK3 | 1.55489697 |
| 21 | PLK2 | 1.49404707 |
| 22 | DAPK3 | 1.36194804 |
| 23 | PAK1 | 1.34365832 |
| 24 | ADRBK2 | 1.33444980 |
| 25 | HCK | 1.26857970 |
| 26 | LMTK2 | 1.24861977 |
| 27 | ACVR1B | 1.17237808 |
| 28 | PIM2 | 1.15794331 |
| 29 | PNCK | 1.15646492 |
| 30 | TLK1 | 1.12523678 |
| 31 | BLK | 1.10892686 |
| 32 | IKBKB | 1.09520968 |
| 33 | LYN | 1.06409553 |
| 34 | TNIK | 1.06248007 |
| 35 | EPHB2 | 1.05172100 |
| 36 | STK24 | 1.04130760 |
| 37 | FES | 1.03874424 |
| 38 | TNK2 | 1.03507753 |
| 39 | MATK | 0.97315267 |
| 40 | EPHA3 | 0.91750829 |
| 41 | MAP2K3 | 0.87902338 |
| 42 | ADRBK1 | 0.86791931 |
| 43 | MAP3K5 | 0.86059743 |
| 44 | TRIM28 | 0.85553167 |
| 45 | RET | 0.84184294 |
| 46 | DAPK2 | 0.83641050 |
| 47 | PKN1 | 0.81959375 |
| 48 | ERBB2 | 0.80606636 |
| 49 | TAOK2 | 0.79275412 |
| 50 | IRAK1 | 0.76904217 |
| 51 | PRKD1 | 0.76648118 |
| 52 | MARK3 | 0.76339506 |
| 53 | ITK | 0.75966782 |
| 54 | NUAK1 | 0.72620218 |
| 55 | FER | 0.72410803 |
| 56 | SIK3 | 0.71493519 |
| 57 | ARAF | 0.71249306 |
| 58 | TESK2 | 0.69858098 |
| 59 | BMPR1B | 0.65884231 |
| 60 | TXK | 0.65683094 |
| 61 | MINK1 | 0.65109415 |
| 62 | DAPK1 | 0.62334619 |
| 63 | MAP4K2 | 0.58043460 |
| 64 | MAPK12 | 0.53832216 |
| 65 | CSK | 0.53744389 |
| 66 | PDGFRB | 0.53015350 |
| 67 | PRKACG | 0.52141416 |
| 68 | TAOK1 | 0.51306636 |
| 69 | MAP3K12 | 0.49840356 |
| 70 | MAPK13 | 0.44584057 |
| 71 | MAP2K1 | 0.43801133 |
| 72 | PDK1 | 0.43628977 |
| 73 | GRK1 | 0.43319261 |
| 74 | PAK3 | 0.42372341 |
| 75 | PRKG1 | 0.40520686 |
| 76 | ZAK | 0.40488336 |
| 77 | FYN | 0.39617287 |
| 78 | STK4 | 0.39240947 |
| 79 | ROCK1 | 0.36287748 |
| 80 | LCK | 0.35226573 |
| 81 | MAP3K3 | 0.35196008 |
| 82 | CDK14 | 0.33730990 |
| 83 | PDPK1 | 0.33356152 |
| 84 | PRKCD | 0.32481671 |
| 85 | PRKCB | 0.29725334 |
| 86 | IRAK3 | 0.28496268 |
| 87 | PRKCA | 0.27274334 |
| 88 | CDK8 | 0.26164435 |
| 89 | JAK2 | 0.25849745 |
| 90 | CAMK2G | 0.25244931 |
| 91 | SRC | 0.25118589 |
| 92 | EPHB1 | 0.24359378 |
| 93 | IGF1R | 0.23801597 |
| 94 | DYRK1A | 0.22522171 |
| 95 | PRKCQ | 0.22514443 |
| 96 | CAMK2A | 0.21528532 |
| 97 | YES1 | 0.21489992 |
| 98 | PRKCE | 0.20970480 |
| 99 | IRAK2 | 0.20579441 |
| 100 | PIM1 | 0.19981870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.73822139 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.86221297 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.28413582 |
| 4 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.69339513 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.57229974 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.32845640 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.30285076 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17334607 |
| 9 | Gap junction_Homo sapiens_hsa04540 | 2.03383343 |
| 10 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.86281922 |
| 11 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.85735732 |
| 12 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.83701402 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.77057572 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.70827479 |
| 15 | Alcoholism_Homo sapiens_hsa05034 | 1.66414295 |
| 16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.53990185 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51310857 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48658118 |
| 19 | Endocytosis_Homo sapiens_hsa04144 | 1.38391027 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.33396228 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.26109253 |
| 22 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.25132013 |
| 23 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.21294390 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18947607 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14920335 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12468653 |
| 27 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08036575 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07297688 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05418899 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00608516 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99966005 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98916971 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 0.97858327 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96533063 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 0.95672249 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 0.93477309 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92417610 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 0.88767962 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86793851 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 0.86757910 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85115849 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83241496 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81901605 |
| 44 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.81017577 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.80449885 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77628886 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75478988 |
| 48 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72989615 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 0.70869530 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70425234 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70030958 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68637874 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66825199 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66675414 |
| 55 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66172925 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65735290 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.65450565 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61073521 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60344559 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60046932 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59166818 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58669263 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58296746 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57439085 |
| 65 | Melanoma_Homo sapiens_hsa05218 | 0.55218359 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54514089 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54458405 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53231350 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52674109 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52573925 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52314487 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51899822 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50939479 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50754851 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50311426 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.50124733 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.48972514 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48032053 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47417963 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45414646 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.45304045 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45077960 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44361007 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43181259 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.42476301 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42232822 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41759517 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41130703 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40169067 |
| 90 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40076041 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.37706332 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.37389907 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37293080 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36941392 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36351034 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.36242820 |
| 97 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35366955 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.34402545 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33089867 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32713861 |

